• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基因编码激素受体 ESR1、ESR2 和 LHCGR 多态性与睾丸生殖细胞癌风险和临床特征的关联。

Association of polymorphisms in genes encoding hormone receptors ESR1, ESR2 and LHCGR with the risk and clinical features of testicular germ cell cancer.

机构信息

Department of Clinical Sciences, Molecular Reproductive Medicine, Lund University, Sweden.

出版信息

Mol Cell Endocrinol. 2012 Apr 4;351(2):279-85. doi: 10.1016/j.mce.2011.12.018. Epub 2012 Jan 5.

DOI:10.1016/j.mce.2011.12.018
PMID:22245602
Abstract

Testicular germ cell cancer (TGCC) is the most common malignancy in young men. Genetic variants known to be associated with risk of TGCC only partially account for the observed familial risks. We aimed to identify additional polymorphisms associated with risk as well as histological and clinical features of TGCC in 367 patients and 214 controls. Polymorphisms in ESR2 (rs1256063; OR=0.53, 95% CI: 0.35-0.79) and LHCGR (rs4597581; OR=0.68, 95% CI: 0.51-0.89, and rs4953617; OR=1.88, 95% CI: 1.21-2.94) associated with risk of TGCC. Polymorphisms in ESR1 (rs9397080; OR=1.85, 95% CI: 1.18-2.91) and LHCGR (rs7371084; OR=2.37, 95% CI: 1.26-4.49) associated with risk of seminoma and metastasis, respectively. SNPs in ESR1 (rs9397080) and LHCGR (rs7371084) were predictors of higher LH levels and higher androgen sensitivity index in healthy subjects. The results suggest that polymorphisms in ESR1, ESR2 and LHCGR contribute to the risk of developing TGCC, histological subtype, and risk to metastasis.

摘要

睾丸生殖细胞癌(TGCC)是年轻男性中最常见的恶性肿瘤。已知与 TGCC 风险相关的遗传变异仅部分解释了观察到的家族风险。我们旨在确定与 TGCC 的风险以及组织学和临床特征相关的其他多态性,在 367 名患者和 214 名对照中。ESR2(rs1256063;OR=0.53,95%CI:0.35-0.79)和 LHCGR(rs4597581;OR=0.68,95%CI:0.51-0.89,和 rs4953617;OR=1.88,95%CI:1.21-2.94)中的多态性与 TGCC 的风险相关。ESR1(rs9397080;OR=1.85,95%CI:1.18-2.91)和 LHCGR(rs7371084;OR=2.37,95%CI:1.26-4.49)中的多态性与精原细胞瘤和转移的风险相关。ESR1(rs9397080)和 LHCGR(rs7371084)中的 SNP 是健康受试者中 LH 水平升高和雄激素敏感性指数升高的预测因子。结果表明,ESR1、ESR2 和 LHCGR 中的多态性有助于 TGCC 的发病风险、组织学亚型和转移风险。

相似文献

1
Association of polymorphisms in genes encoding hormone receptors ESR1, ESR2 and LHCGR with the risk and clinical features of testicular germ cell cancer.基因编码激素受体 ESR1、ESR2 和 LHCGR 多态性与睾丸生殖细胞癌风险和临床特征的关联。
Mol Cell Endocrinol. 2012 Apr 4;351(2):279-85. doi: 10.1016/j.mce.2011.12.018. Epub 2012 Jan 5.
2
Association of testicular germ cell tumor with polymorphisms in estrogen receptor and steroid metabolism genes.睾丸生殖细胞肿瘤与雌激素受体和类固醇代谢基因多态性的关联。
Endocr Relat Cancer. 2010 Jan 29;17(1):17-25. doi: 10.1677/ERC-09-0176. Print 2010 Mar.
3
Polymorphic variation in the androgen receptor gene: association with risk of testicular germ cell cancer and metastatic disease.雄激素受体基因的多态性变化:与睾丸生殖细胞癌和转移性疾病的风险相关。
Eur J Cancer. 2011 Feb;47(3):413-9. doi: 10.1016/j.ejca.2010.08.017. Epub 2010 Sep 27.
4
Genetic variations associated with the effect of testicular cancer treatment on gonadal hormones.与睾丸癌治疗对性腺激素影响相关的基因变异。
Hum Reprod. 2014 Dec;29(12):2844-51. doi: 10.1093/humrep/deu274. Epub 2014 Oct 21.
5
Is the FSHR 2039A>G variant associated with susceptibility to testicular germ cell cancer?FSHR 2039A>G 变异是否与睾丸生殖细胞癌易感性相关?
Andrology. 2018 Jan;6(1):176-183. doi: 10.1111/andr.12440. Epub 2017 Nov 27.
6
Semen quality and reproductive hormones before orchiectomy in men with testicular cancer.睾丸癌男性患者睾丸切除术前的精液质量和生殖激素
J Clin Oncol. 1999 Mar;17(3):941-7. doi: 10.1200/JCO.1999.17.3.941.
7
Gene variations in sex hormone pathways and the risk of testicular germ cell tumour: a case-parent triad study in a Norwegian-Swedish population.性激素通路基因变异与睾丸生殖细胞肿瘤风险:在挪威-瑞典人群中进行的病例-父母三体型研究。
Hum Reprod. 2012 May;27(5):1525-35. doi: 10.1093/humrep/des075. Epub 2012 Mar 8.
8
Association of polymorphisms in the estrogen receptors alpha, and beta (ESR1, ESR2) with the occurrence of male infertility and semen parameters.雌激素受体 α 和 β(ESR1、ESR2)基因多态性与男性不育及精液参数的关系。
J Steroid Biochem Mol Biol. 2010 Oct;122(4):193-203. doi: 10.1016/j.jsbmb.2010.06.011. Epub 2010 Jun 25.
9
Risk of testicular germ cell cancer in relation to variation in maternal and offspring cytochrome p450 genes involved in catechol estrogen metabolism.与参与儿茶酚雌激素代谢的母体和子代细胞色素P450基因变异相关的睾丸生殖细胞癌风险。
Cancer Epidemiol Biomarkers Prev. 2005 Sep;14(9):2183-90. doi: 10.1158/1055-9965.EPI-04-0749.
10
ESR1 and ESR2 polymorphisms in the BIG 1-98 trial comparing adjuvant letrozole versus tamoxifen or their sequence for early breast cancer.在比较来曲唑与他莫昔芬辅助治疗早期乳腺癌的BIG 1-98试验中ESR1和ESR2基因多态性或其序列
Breast Cancer Res Treat. 2015 Dec;154(3):543-55. doi: 10.1007/s10549-015-3634-6. Epub 2015 Nov 21.

引用本文的文献

1
An Integrated Analysis of Network Pharmacology, Molecular Docking, and Experiment Validation to Explore the New Candidate Active Component and Mechanism of Coupled-Herbs in Treating Oligoasthenozoospermia.基于网络药理学、分子对接和实验验证的综合分析,探讨治疗少弱精子症的药对新候选活性成分及作用机制。
Drug Des Devel Ther. 2021 May 17;15:2059-2089. doi: 10.2147/DDDT.S307015. eCollection 2021.
2
ESR1 as a recurrence-related gene in intrahepatic cholangiocarcinoma: a weighted gene coexpression network analysis.ESR1作为肝内胆管癌中与复发相关的基因:加权基因共表达网络分析
Cancer Cell Int. 2021 Apr 17;21(1):225. doi: 10.1186/s12935-021-01929-5.
3
GPER and Testicular Germ Cell Cancer.
G蛋白偶联雌激素受体与睾丸生殖细胞癌
Front Endocrinol (Lausanne). 2021 Jan 26;11:600404. doi: 10.3389/fendo.2020.600404. eCollection 2020.
4
Network pharmacology integrated molecular docking reveals the bioactive components and potential targets of Morinda officinalis-Lycium barbarum coupled-herbs against oligoasthenozoospermia.网络药理学结合分子对接揭示了巴戟天-枸杞药对治疗少弱精子症的活性成分及潜在作用靶点。
Sci Rep. 2021 Jan 26;11(1):2220. doi: 10.1038/s41598-020-80780-6.
5
Polymorphism in the Alternative Donor Site of the Cryptic Exon of LHCGR: Functional Consequences and Associations with Testosterone Level.LHCGR 隐匿外显子替代供体位点多态性:功能后果及与睾酮水平的关联。
Sci Rep. 2017 Apr 3;7:45699. doi: 10.1038/srep45699.
6
Influence of VEGFR and LHCGR on endometrial adenocarcinoma.血管内皮生长因子受体(VEGFR)和促黄体生成素/绒毛膜促性腺激素受体(LHCGR)对子宫内膜腺癌的影响。
Oncol Lett. 2016 Sep;12(3):2092-2098. doi: 10.3892/ol.2016.4906. Epub 2016 Jul 22.
7
GPER Signaling in Spermatogenesis and Testicular Tumors.G蛋白偶联雌激素受体信号通路在精子发生和睾丸肿瘤中的作用
Front Endocrinol (Lausanne). 2014 Mar 6;5:30. doi: 10.3389/fendo.2014.00030. eCollection 2014.
8
Luteinizing hormone and human chorionic gonadotropin: distinguishing unique physiologic roles.促黄体生成素和人绒毛膜促性腺激素:区分独特的生理作用。
Gynecol Endocrinol. 2014 Mar;30(3):174-81. doi: 10.3109/09513590.2013.859670. Epub 2013 Nov 27.
9
Global incidence and outcome of testicular cancer.睾丸癌的全球发病率及预后
Clin Epidemiol. 2013 Oct 17;5:417-27. doi: 10.2147/CLEP.S34430.
10
Integrating multiple oestrogen receptor alpha ChIP studies: overlap with disease susceptibility regions, DNase I hypersensitivity peaks and gene expression.整合多个雌激素受体α ChIP 研究:与疾病易感性区域、DNase I 超敏峰和基因表达的重叠。
BMC Med Genomics. 2013 Oct 30;6:45. doi: 10.1186/1755-8794-6-45.